Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Affymax Inc AFFY

Healthcare Biotechnology
Affymax, Inc. is a biopharmaceutical company. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with... see more

Recent & Breaking News (GREY:AFFY)

Affymax Adopts Tax Benefit Preservation Plan to Protect Net Operating Loss Carryforwards

Business Wire November 26, 2014

Affymax, Inc. Announces a Special Cash Distribution and the Appointment of a New Director and Chief Executive Officer

Business Wire November 26, 2014

Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Affymax, Inc. Class Action and Settlement Hearing -- AFFY

GlobeNewswire November 26, 2014

Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Affymax, Inc. Class Action and Settlement Hearing -- AFFY

GlobeNewswire November 17, 2014

Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Affymax, Inc. Class Action and Settlement Hearing -- AFFY

GlobeNewswire November 3, 2014

Xstelos Announces Intention To Vote Against Affymax's Plan Of Liquidation At September 23, 2014 Special Meeting of Shareholders

PR Newswire September 19, 2014

Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Affymax, Inc. Class Action and Settlement Hearing - AFFY

Business Wire September 12, 2014

Affymax Reports Second Quarter 2014 Financial Results

Business Wire July 31, 2014

Affymax Board Announces Decision to Dissolve the Company

Business Wire June 24, 2014

Affymax Inc., OncoSec Medical Inc. See Share Price Decrease In Rough Day For Biotech Sector

Accesswire June 16, 2014

Affymax and Takeda Announce Termination of Omontys® (peginesatide) Product Collaboration and License Agreement

Business Wire June 13, 2014

TrendingWallStreet.com Reports Volume Analysis on SD, ENIP, AFFY, and CRIS

Accesswire November 7, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on AFFY, BMRN, DNDN and HTBX

Accesswire September 19, 2013

GSAT, AFFY, AAMRQ and NVIV added to OTC Active Stock Watch List at EPR

Accesswire August 27, 2013

SOUL, XUII, PMCM and AFFY added to OTC Stock Watch List at GSR

Accesswire July 30, 2013

XUII, SOUL, PEII and AFFY added to OTC Stock Watch List at GSR

Accesswire July 26, 2013

Start Making Profits Now With CLNT, AFFY, TSLA and CLSN

Marketwired June 19, 2013

In The Know, Smart Investing in CLNT, AFFY, TSLA and CLSN

Marketwired June 18, 2013

Special Situation Coming Soon, A Look Inside CLNT, AFFY, TSLA and CLSN

Marketwired June 17, 2013

Special Offer for Shareholders of CLNT, AFFY, TSLA and CLSN

Marketwired June 14, 2013